NEW YORK (
) hit a new 52-week high Monday as it is currently trading at $60.64, above its previous 52-week high of $60.56 with 344,165 shares traded as of 9:35 a.m. ET. Average volume has been 6.4 million shares over the past 30 days.
Abbott has a market cap of $87.21 billion and is part of the
industry. Shares are up 7.4% year to date as of the close of trading on Friday.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company has a P/E ratio of 20, above the average drugs industry P/E ratio of 19.4 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
TheStreet Ratings rates Abbott as a
. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full
52-week high stocks
or get investment ideas from our